Effect of Cannabidiol on Drop Seizures in the Lennox-Gastaut Syndrome
NEJM 378:1888-1897, Devinsky, O.,et al, 2018
Switching the Manufacturer of Antiepileptic Drugs is Associated with Higher Risk of Seizures: A Nationwide Study of Prescription Data in Germany
Ann Neurol 84:918-925, Lang, J.D.,et al, 2018
Antiseizure Medications
Neurol 86:e187-e188, Karceski, S., 2016
Evidence-based Guideline: Antiepileptic Drug Selection for People with HIV/AIDS
Neurol 78:139-145, Birbeck,G.L.,et al, 2012
Assessing Bioequivalence of Generic Antiepilepsy Drugs
Ann Neurol 70:221-228,192, Krauss, G.L.,et al, 2011
Generic Anticonvulsant Use in Children: Do We Have Evidence to Recommend Brand Formulations?
Arch Neurol 66:1417-1418, Hamiwka,L., 2009
Generic Substitution in the Treatment of Epilepsy: Case Evidence of Breakthrough Seizures
Neurol 71:525-530, Berg,M.J.,et al., 2008
Initial Management of Epilepsy
NEJM 359:166-176, French,J.A. &Pedley,T.A., 2008
Lamotrigine Extended-Release as Adjunctive Therapy for Partial Seizures
Neurol 69:1610-1618, Naritoku,D.K.,et al, 2007
Practice Parameter: Diagnostic Assessment of the Child with Status Epilepticus (An Evidence-Based Review): Report of the Quality Standards Subcommittee of the American Academy of Neurology and the practice Committee of the Child Neurology Society
Neurol 67:1542-1550, Riviello,J.J. Jr.,et al, 2006
The New Antiepileptic Drugs, Scientific Review
JAMA 291:605-614, LaRoche,S.M.&Helmers,S.L., 2004
Randomized, Concentration-Controlled Trial of Topiramate in Refractory Focal Epilepsy
Neurol 61:1210-1218, Christensen,J.,et al, 2003
Subtherapeutic Free Phenytoin Levels Following Fosphenytoin Therapy in Status Epilepticus
Neurol 58:147-148, Koul,R. &Deleu,D., 2002
Patients with Refractory Seizures
NEJM 340:1565-1570, Devinsky,O, 1999
Management Issues for Women with Epilepsy,A Review of the Literature
Neurol 51:949-956, Zahn,C.A.,et al, 1998
Analysis of Prenatal and Gestational Care Given to Women with Epilepsy
Neurol 51:1039-1045, Seale,C.G.,et al, 1998
Practice Parameter,Management Issues for Women with Epilepsy (Summary Statement)
Neurol 51:944-948, Rpt of the Quality Stnds Subcmte AAN, 1998
Antiepileptic Drugs
NEJM 334:168-175, Brodie,M.J.&Dichter,M.A., 1996
The Use of Parenteral Antiepileptic Drugs & The Role of Fosphenytoin
(Suppl Editor) , Neurol 46:S1-S2896., Wilder,B.J., 1996
Optimizing Long-Term Patient Compliance
Neurol 45(Suppl 1):S25-S28, Cramer,J.A., 1995
Long-Term Therapeutic Management of Epilepsy
Ann Int Med 120:411-422, French,J., 1994
Epilepsy
JNNP 57:264-277, Chadwick,D., 1994
Status Epilepticus at an Urban Public Hospital in the 1980s
Neurol 43:483-488, Lowenstein,D.H.&Alldredge,B.K., 1993
Epilepsy and Pregnancy
BMJ 307:492-495, O'Brien,M.D.&Gilmour-White,S., 1993
The Evaluation and Treatment of Seizures
NEJM 323:1468-1474, Scheuer,M.L.&Pedley,T.A., 1990
Carbamazepine Update
Editorial, Lancet 2:595-5971989., , 1989
Breakthrough Seizure Following Substitution of Depakene Capsules with a Generic Product
Neurol 37:1885, MacDonald,J.T., 1987
Methsuximide for Refractory Complex Partial Seizures
Neurol 31:741-744, Wilder,B.J.,et al, 1981
Valproic Acid
NEJM 302:661-666, Brown,T.R., 1980
Valproic Acid, Review of a New Antiepileptic Drug
Arch Neurol 36:393-398, Bruni,J.,et al, 1979
Sodium Valproate in the Treatment of Intractable Seizure Disorders:A Clinical & Electroencephalographic Study
Neurol 28:152, Adams,D.,et al, 1978
Carbamazepine-A Double-blind Comparison with Phenytoin
Neurol 27:511, Troupin,A.,et al, 1977